Anti-fibrotic Potential of AT(2) Receptor Agonists

There are a number of therapeutic targets to treat organ fibrosis that are under investigation in preclinical models. There is increasing evidence that stimulation of the angiotensin II type 2 receptor (AT(2)R) is a novel anti-fibrotic strategy and we have reviewed the published in vivo preclinical...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Pharmacol
Main Authors: Wang, Yan, Del Borgo, Mark, Lee, Huey W., Baraldi, Dhaniel, Hirmiz, Baydaa, Gaspari, Tracey A., Denton, Kate M., Aguilar, Marie-Isabel, Samuel, Chrishan S., Widdop, Robert E.
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2017
Assuntos:
Pharmacology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5583590/
https://ncbi.nlm.nih.gov/pubmed/28912715
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2017.00564
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados